Good digging fouremm.

I get the impression that this company has no understanding of the value of their assets. I also feel there is no strategic plan nor direction. It just seems to be a business of hit and miss.

It seems to me that with all of the exciting science happening that ZCC should be enlisting the best biotech finance experts in the world to be building strategic options and valuations and be prepared to capitalize on opportunities. I'm left with the impression that this company is run by knee jerk reactions to survive and there is no vision what-so-ever.

This is a ruderless ship. I wish I had data to give me more confidence.

Toinv